Ovation Pharmaceuticals Announces Nationwide Availability Of Xenazine* (tetrabenazine) Tablets In U.S. for Chorea Associated with Huntington’s Disease
November 24, 2008
OVATION Pharmaceuticals, Inc. announced today that Xenazine (tetrabenazine) Tablets, recently approved to treat chorea associated with Huntington's disease, is now available throughout the U.S

PROPEL Intel - October 2008
October 31, 2008
PROPEL Intel is a monthly e-newsletter for entrepreneurs, early stage life sciences companies and others in the community who work with PROPEL and the iBIO Entrepreneurship Center.

Chicago Public Schools Receive Major Corporate Donation For Science Education
October 23, 2008
Baxter International Inc. Donates $5 Million to Develop Science Schools and District-Wide Biotech Instruction Program

IPM Named a “Top Small Workplace” by The Wall Street Journal and Winning Workplaces
October 17, 2008
Integrated Project Management Company, Inc. (IPM) announced on Oct. 13 that it is one of 15 companies nationwide named a “Top Small Workplace” by The Wall Street Journal and Winning Workplaces.

ATryn* (antithrombin alfa) BLA Filing Accepted By FDA
October 06, 2008
OVATION Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ATryn*.

OVATION Pharmaceuticals Acquires Rights To Commercialize Xenazine® In U.S. For Chorea Associated With Huntington's Disease
October 01, 2008
OVATION Pharmaceuticals, Inc. announced today that it has acquired from Prestwick Pharmaceuticals the exclusive license in the United States to commercialize Xenazine®.

iBIO President’s - President's Letter – September 2008
September 30, 2008
Before the Fall (Disappears)

PROPEL Intel - September 2008
September 30, 2008
PROPEL Intel is a monthly e-newsletter for entrepreneurs, early stage life sciences companies and others in the community who work with PROPEL and the iBIO Entrepreneurship Center.

2008 BIO International Convention Workshop Series: Following the Paths to Success in Biotechnology
September 29, 2008
The iBIO Entrepreneurship Center along with PROPEL invite you to attend any of the workshops originally recorded at the 2008 BIO International Convention in San Diego, California now available through iBIO on CD-rom.

Three Nanotechnology Companies Expand At The Illinois Science + Technology Park; One New Nanotechnology Tenant Announced
September 24, 2008
Forest City Science + Technology Group announced today that three existing tenants have leased an additional 16,033-square-feet of space and one new tenant has leased 2,769 square feet of space at the IS+TP.